Dr. Rohit Aggarwal, MD

Dr. Aggarwal practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Dr. Aggarwal's NPI, 1538340138, was assigned on November 26, 2007. Dr. Aggarwal graduated from Delhi University College of Medical Sciences in 2003. Dr. Aggarwal holds Pennsylvania license MD436376.

Dr. Aggarwal's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Dr. Aggarwal's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Dr. Aggarwal is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Dr. Aggarwal to 5 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Aggarwal practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Aggarwal's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Aggarwal is board certified in rheumatology by the American Board of Internal Medicine. Dmand AI has Dr. Aggarwal's licenses on file in 4 states: Pennsylvania, Florida, Maine and Illinois.

Dmand AI lists arteritis, gout, lupus, muscle disease, muscle pain, fibromyalgia, and limb pain, osteoporosis and rheumatoid arthritis among the conditions Dr. Aggarwal treats.

CMS data shows 209 Medicare services from Dr. Aggarwal across 2 procedure codes in 2024, for 82 Medicare patients. Medicare paid $13,016 for them.

CMS counts 82 Medicare patients who saw Dr. Aggarwal in 2024. The largest group is 65 to 74, with 43 patients. 75% of them have high blood pressure, and 73% have high cholesterol. Their average risk score is 1.73, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Aggarwal's median patient age at 69, with 66% women.

In 2024, Dr. Aggarwal wrote 1,813 Medicare Part D claims for 220 patients. 78% of them were for generic drugs. CMS names the drug for 1,591 of them, across 37 drugs with 11 or more claims each, at $1,976,292 in total drug cost. In 2023, CMS named 1,654 claims across 39 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Dr. Aggarwal for performance year 2024, reported as part of a group. Dr. Aggarwal accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Aggarwal as offering telehealth.

Dmand AI links 228 papers to Dr. Aggarwal, published from 2008 to 2025. 2024 was the busiest year, with 16. The most frequent topics are Myositis, COVID-19 and Dermatomyositis. Dr. Aggarwal has published most often in Rheumatology (Oxford). Dr. Aggarwal's most frequent co-authors are Vikas Agarwal, MD, Siamak Moghadam-Kia, MD, MPH and Tulika Chatterjee, MD.

Dmand AI links Dr. Aggarwal to 8 clinical trials, 4 of them phase 2 studies. Conditions studied include Dermatomyositis, Polymyositis and Myositis. Octapharma sponsors the most, 3. Open Payments lists research payments to Dr. Aggarwal that name 3 trials.

CMS Open Payments shows 422 general payments to Dr. Aggarwal from 29 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Pfizer Inc. paid the most, $237,346. It also lists 12 research payments totaling $94,763 from 2017 to 2024, naming 3 clinical trials.

Dmand AI lists 2 awards for Dr. Aggarwal, most recently CMS Stage 1 EHR in 2011.

Dr. Aggarwal graduated from Delhi University College of Medical Sciences in 2003.

Dr. Aggarwal is in network with 12 carriers, including Aetna, Excellus BlueCross BlueShield and United Healthcare. HMO plans come from the most carriers, 6. Check the plan with the practice before a visit.